
1. euro surveill. 2016;21(13). doi: 10.2807/1560-7917.es.2016.21.13.30179.

effectiveness seasonal influenza vaccine preventing laboratory-confirmed
influenza primary care united kingdom: 2015/16 mid-season results.

pebody r(1), warburton f, ellis j, andrews n, potts a, cottrell s, johnston j,
reynolds a, gunson r, thompson c, galiano m, robertson c, mullett d, gallagher n,
sinnathamby m, yonova i, moore c, mcmenamin j, de lusignan s, zambon m.

author information: 
(1)public health england, london, united kingdom.

in 2015/16, influenza season united kingdom dominated influenza
a(h1n1)pdm09 circulation. virus characterisation indicated emergence of
genetic clusters, majority antigenically similar current
influenza a(h1n1)pdm09 vaccine strain. mid-season vaccine effectiveness (ve)
estimates show adjusted 41.5% (95% confidence interval (ci): 3.0-64.7)
against influenza-confirmed primary care consultations 49.1% (95% ci:
9.3-71.5) influenza a(h1n1)pdm09. estimates show levels of
protection similar 2010/11 season, strain first used 
seasonal vaccine.

doi: 10.2807/1560-7917.es.2016.21.13.30179 
pmid: 27074651  [indexed medline]

